Clinical Trials
61 trialsCOSMIC
ASH Research Collaborative
Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
Dana-Farber Cancer Institute
Pre-malignant States to Hematologic Malignancies in Firefighters
Wake Forest University Health Sciences
AI
Zhongnan Hospital
NIRVANA
Columbia University
LIBERATE
University Health Network, Toronto
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
UNC Lineberger Comprehensive Cancer Center
A Study of the Bortezomib, Lenalidomide, and Dexamethasone Regimen for the Treatment of Newly Diagnosed Multiple Myeloma Patients
The First Affiliated Hospital of Soochow University
LOOMIS
Oxford University Hospitals NHS Trust
MYRACLE
Nantes University Hospital
Registry of Older Patients With Cancer
UNC Lineberger Comprehensive Cancer Center
The Burden of Multiple Myeloma on Patients and Caregivers Quality of Life: a Canadian Real-World Study
PeriPharm
Longitudinal Data Registry of Plasma Cell Dyscrasia
Shanghai Zhongshan Hospital
Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey
UNC Lineberger Comprehensive Cancer Center
Survivorship
University of Modena and Reggio Emilia
Mobile Health Device Study for Myeloma Patients
Memorial Sloan Kettering Cancer Center
ASH Research Collaborative Data Hub
ASH Research Collaborative
HemaTMA
Tampere University Hospital
FATIGUE
University of Aberdeen
genetics MM
Siriraj Hospital
Bergamo Lymphoid Cancer Registry
A.O. Ospedale Papa Giovanni XXIII
Registry PCD
Siriraj Hospital
ENROL
Hospital Universitari Vall d'Hebron Research Institute
CoMMpass
Multiple Myeloma Research Foundation
The Value of Systematic Biopsies During Vertebroplasty for the Treatment of Osteoporotic Vertebral Fractures
Centre Hospitalier Universitaire de Nice
GAGNE
University Hospital, Bordeaux
CHIME
The Christie NHS Foundation Trust
Corneal Toxicity in Patients Treated by Belantamab Mafodotin
Centre Hospitalier Universitaire de Saint Etienne
Changing Over Time of Ascorbic Acid After Chemotherapy
Maastricht University Medical Center
iTIMM
Institute of Cancer Research, United Kingdom
Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma
OHSU Knight Cancer Institute
SPACE2
Weprom
DECIMA
Guy's and St Thomas' NHS Foundation Trust
THERMAL
Malaghan Institute of Medical Research
Collecting and Storing Blood Samples From Patients With Cancer
Rutgers, The State University of New Jersey
MYMO
Centre Hospitalier Universitaire de Nīmes
ICARE
European Georges Pompidou Hospital
Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation
Memorial Sloan Kettering Cancer Center
Place of the Hevylite Test in the Evaluation of MRD in Myeloma
University Hospital, Montpellier
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Vanderbilt-Ingram Cancer Center
Vascular Functions in Myeloma Patients During Anti-tumor Therapy
University Hospital, Essen
Comprehensive Frailty Assessment
Ohio State University Comprehensive Cancer Center
Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant
The Cleveland Clinic
Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant
City of Hope Medical Center
Blood Samples From Patients on a Clinical Trial to CINV During HSCT
OHSU Knight Cancer Institute
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
Vanderbilt University Medical Center
Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy
UNC Lineberger Comprehensive Cancer Center
Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant
Duke University
Chemotherapy-Induced Peripheral Neuropathy Survey
M.D. Anderson Cancer Center
Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma
Barbara Ann Karmanos Cancer Institute